Global burden of osteoarthritis: Prevalence and temporal trends from 1990 to 2019
International Journal of Rheumatic Diseases · 2024-08 · 27 (8)
DOI: 10.1111/1756-185x.15285 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 08.08.2024. Verfasst von Xiao-Xiao Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Global Burden of Disease, Osteoarthritis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: The National Natural Science Foundation of China, Anhui Provincial Natural Science Foundation, Research Fund of Anhui Institute of Translational Medicine.
Abstract (Originalsprache)
Objective
To investigate the age‐standardized prevalence rate (ASPR) and temporal trends for hip, knee, hand, and other osteoarthritis (OA) at a global, continental, and national level.
Design
The estimates and 95% uncertainty intervals (UIs) for case number and ASPR of OA were derived from the Global Burden of Diseases Study (GBD) 2019. The joinpoint regression analysis was utilized to examine the temporal trends from 1990 to 2019.
Results
In 2019, the global ASPR of hip, knee, hand, and other OA was 400.95 (95% UI: 312.77–499.41), 4375.95 (95% UI: 3793.04–5004.9), 1726.38 (95% UI: 1319.91–2254.85), and 745.62 (95% UI: 570.16–939.8). As for the ASPR of hip OA, hand OA, and other OA, Europe and America had higher rates than Asia and Africa, and Asia was second only to America in knee OA ASPRs. The period 1990–2019, the ASPR at global level dropped significantly for hand OA (AAPC = −0.4%, 95% CI: −0.47 to −0.34) and increased significantly for hip OA (AAPC = 0.43%, 95% CI: 0.39–0.46), knee OA (AAPC = 0.17%, 95% CI: 0.09–0.24) and other OA (AAPC = 0.16%, 95% CI: 0.15–0.17). Different continents, countries, and periods demonstrated significant changes.
Conclusions
Globally, America has the highest OA burden and Asia has a higher knee OA burden. Appropriate prevention and control measures to reduce modifiable risk factors are needed to reduce the burden of OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Institute of Ophthalmology, Beijing Ophthalmology & Visual Sciences Key Laboratory, Capital Medical University, Beijing, China.
- Department of Preventive Medicine, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
- Teaching Center for Preventive Medicine, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
ORCID-Profile: Peng Wang, Hai-Feng Pan
Förderung
- The National Natural Science Foundation of China
- Anhui Provincial Natural Science Foundation
- Research Fund of Anhui Institute of Translational Medicine
- Research Funds of Center for Big Data and Population Health of IHM
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
Zitieren
APA
Li, X. X., Cao, F., Zhao, C. N., Ge, M., Wei, H. F., Tang, J., Xu, W. L., Wang, S., Gao, M., Wang, P., & Pan, H. F. (2024). Global burden of osteoarthritis: Prevalence and temporal trends from 1990 to 2019. International Journal of Rheumatic Diseases, 27(8). https://doi.org/10.1111/1756-185x.15285
Vancouver
Li XX, Cao F, Zhao CN, Ge M, Wei HF, Tang J, et al. Global burden of osteoarthritis: Prevalence and temporal trends from 1990 to 2019. International Journal of Rheumatic Diseases. 2024;27(8). doi:10.1111/1756-185x.15285
BibTeX
@article{Li2024,
author = {Li, Xiao-Xiao and Cao, Fan and Zhao, Chan-Na and Ge, Man and Wei, Hai-Fen and Tang, Jian and Xu, Wen-Li and Wang, Shuo and Gao, Meng and Wang, Peng and Pan, Hai-Feng},
title = {Global burden of osteoarthritis: Prevalence and temporal trends from 1990 to 2019},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
volume = {27},
number = {8},
doi = {10.1111/1756-185x.15285}
}
EUVIMED